Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis MARKET DYNAMICS Stringent cost and payer controls OPPORTUNITIES Impact Level Increasing studies on oral GLP-1 Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis Rapid expansion of manufacturing capacity is driving growth across the pharmaceutical market, especially for high-demand drugs like GLP-1 analogs
For Wegovy (2.4 mg), nausea affects approximately 44% of patients, with diarrhea (30%), vomiting (24%), and constipation (24%) also commonly reported
Investigated for energy expenditure and thermogenic activity
If you do decide to try GLP-1 medications, your healthcare provider will monitor you closely for side effects and adjust your treatment as needed
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: A report of the american college of cardiology/american heart association task force on clinical practice guidelines